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by recent investigators.4 However, Imparato et al5 and
Myhre6 were able to maintain comparable results with
SFA endarterectomy using the above approaches. The suc-
cess of synthetic conduits for above-knee reconstruction
further threatened the utility of primary endarterectomy.7-
9 Still, proponents of endarterectomy, particularly in
Europe, have continued to show reasonable results after
femoropopliteal endarterectomy.10-14 These authors sup-
port its utility, particularly in patients with claudication in
whom preservation of an autogenous conduit may be of
importance or in patients in whom an autogenous conduit
is unavailable.
The durability of endovascular intervention for
femoropopliteal occlusive disease continues to be poor in
comparison with similar techniques in the aortoiliac distri-
bution. However, advancements in technology have
improved on the concept of endarterectomy and made it
progressively less invasive. A closed approach to SFA
endarterectomy was first described by Ho et al in 199515
using a single common femoral arteriotomy for complete
SFA endarterectomy with a traditional ringed stripper and
the addition of a modified ring cutter device allowing for
remote detachment of the plaque at its distal extent. They
described encouraging early results with 96% 5-month
patency15,16 of this closed approach combined with pri-
mary stenting of the distal endarterectomy end point,
which stimulated us to test this approach in selected
patients.
Endarterectomy for treatment of arteriosclerotic
occlusive disease was first introduced by dos Santos in
19471 and was popularized for aortoiliac revascularization
by Wylie et al in 1951.2 Its application to infrainguinal
occlusive disease has remained controversial. Early propo-
nents of its utility used either an open approach with direct
endarterectomy and patch angioplasty or a semi-closed
approach with arteriotomy at the proximal and distal
extents of the diseased segment; an internal ringed strip-
per was used to complete the thromboendarterectomy of
the superficial femoral artery (SFA) and popliteal artery.
With the success of autogenous infrainguinal bypass pro-
cedures, the role of SFA endarterectomy came under fur-
ther scrutiny. Darling and Linton3 reported a direct
comparison of endarterectomy and vein bypass graft
showing a clear advantage for bypass graft (patency, 30%
vs 74%). This conclusion has been supported prospectively
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Background: Endovascular superficial femoral artery (SFA) endarterectomy with a ring stripper/cutter and distal stent-
ing has been suggested to have a patency comparable with above-knee bypass surgery. We report our initial experience
with this technique.
Methods: Seventeen patients (13 men and 4 women; mean age, 64 years) with SFA occlusion and above-knee popliteal
reconstitution underwent attempted remote endarterectomy with a ring cutter system combined with primary stenting
of the distal end point. Analysis was performed in a prospective manner with patency rates determined by Kaplan-Meier
life-table analysis.
Results: The indication for operation was claudication in 8 patients, rest pain in 6, and tissue loss in 3. Initial techni-
cal success was achieved in 11 patients (65%). Reasons for technical failure included SFA perforation (4), inability to
traverse a calcified/diseased segment (1), and inability to retract/remove the ring cutter (1). Life-table analysis of all
patients revealed a primary patency at 1 year of 26% ± 11%. Primary-assisted patency was 38% ± 12% at 1 year, with
59% of patients ultimately requiring surgical bypass grafting. In patients in whom initial technical success was achieved,
the 1-year primary and primary-assisted patency rates were 40% and 59%, respectively. There were four reocclusions
requiring surgical revascularization with below-knee popliteal (2) or tibial (2) bypass grafting, 1 symptomatic resteno-
sis requiring repeat angioplasty, and 1 symptomatic restenosis treated conservatively.
Conclusion: The results of endovascular SFA endarterectomy were disappointing, with technical success in less than two
thirds of patients and a 1-year primary patency of only 26%. Remote SFA endarterectomy appears less effective than
above-knee femoropopliteal bypass grafting, and after early failure, patients may require more distal revascularization
for limb salvage. (J Vasc Surg 2001;34:526-31.)
Despite the natural history of SFA stenoses with a 10%
to 15% annual risk of progression to symptomatic signifi-
cance, but a small 1% annual risk of limb loss, a defined
approach to management is lacking.17 Our philosophy of
patients with isolated SFA occlusion and claudication as a
presenting complaint has been to pursue nonsurgical man-
agement including exercise, risk factor modification, and
pharmacologic intervention. To treat those patients who
do not respond to this approach and to address patients
with SFA disease and more-advanced ischemic symptoms
but poor conduit options or prohibitive comorbidity, we
explored the use of remote SFA endarterectomy.
PATIENTS AND METHODS
All data for patients undergoing remote endovascular
SFA endarterectomy at the Dartmouth-Hitchcock Medical
Center over a 12-month period from 1999 to 2000 were
compiled prospectively. The 17 patients in this analysis rep-
resent our entire experience with this technique, including
all patients in whom the procedure was attempted.
Patients were selected for operation on the basis of the
presence of symptomatic lower extremity peripheral vascu-
lar disease as defined by “Recommended standards for
reports dealing with lower extremity ischemia.”18 In all
patients, arterial anatomy was determined and operative
planning was based on preoperative duplex ultrasound
arterial mapping and confirmed with intraoperative con-
trast arteriography. Patients selected for an endovascular
endarterectomy had to demonstrate long-segment SFA
occlusion as the dominant level of disease with reconstitu-
tion of the above-knee popliteal artery free of disease and
at least one-vessel tibial runoff to the foot in the sympto-
matic limb.
The technique of remote endovascular SFA endar-
terectomy was based on the description of Moll et al.15,19
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All patients received epidural anesthesia. An ipsilateral
groin incision was used with dissection and control of the
common femoral artery (CFA), SFA, and profunda
femoris artery. Intraoperative arteriography was per-
formed with a C-arm fluoroscopy imaging system, with
power injection and use of isotonic nonionic contrast
medium. CFA arteriotomy was performed with focal
endarterectomy of the CFA bifurcation as indicated. SFA
endarterectomy was performed under fluoroscopic guid-
ance with the MollRing device (Vascular Architects, San
Jose, Calif). The proximal endarterectomy plane was estab-
lished within the femoral arteriotomy and extended with
the Vollmar ring stripper to the level just distal to the occlu-
sion. The ring cutter was then advanced along the same
plane, the distal extent of the atheroma was cut with the
trigger device, and the atheromatous plaque was retrieved
in its entirety through the CFA arteriotomy (Fig 1). A 25-
to 30-cm endarterectomy cast of the SFA can be achieved
in all cases. The distal extent of the endarterectomy was
confirmed to be adequate with arteriography, and the dis-
tal end point was primarily stented with either a self-
expanding or balloon-expandable device. Completion
arteriography confirmed technical adequacy of each pro-
cedure at the time of surgery (Fig 2). Postoperative
ankle/brachial indices (ABIs) were obtained before
patient discharge.
Routine postoperative surveillance followed the same
surveillance as patients who underwent vein bypass graft-
ing, which included duplex imaging at 1, 6, and 12
months and then annually thereafter. Patency was deter-
mined with duplex scanning of the endarterectomized
SFA. Recurrent stenosis was defined by a focal step-up in
peak systolic velocity greater than 2.5-fold. Primary
Fig 1. Endarterectomized plaque from entire length of SFA
(gross). Intraoperative photograph immediately after endovascu-
lar SFA endarterectomy. Intact full-length plaque in foreground
measuring approximately 28 cm with ring stripper in background
for comparison.
Fig 2. Preprocedural and postprocedural arteriogram with
endovascular endarterectomy and stenting. Intraoperative subtrac-
tion arteriography performed with Phillips BV300 C-arm and
hand-injected nonionic contrast (Visipaque, Nycomed, Princeton,
NJ). A, Preoperative diagnostic image depicting SFA occlusion at
adductor hiatus. B, Completion image showing final technical
result with widely patent SFA into popliteal artery. Ruler is present
for reference.
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patency rates were calculated from the date of surgery to
the date of the most recent follow-up or to the date of
thrombosis or requirement for reintervention. One
patient died of unrelated causes during the follow-up
period; otherwise, no patient was lost to follow-up.
Patency rates were determined with the Kaplan-Meier
life-table method. Univariate life-table comparisons were
made for prognostic variables, followed by multiple logis-
tic regression and Pearson χ2 analysis to examine the sig-
nificance, if any, of the patient characteristics (age, sex,
coronary artery disease, diabetes, hypertension, smoking
history, hyperlipidemia, or dialysis dependence) or preop-
erative vascular status (indication, preoperative ABI, or
runoff) as predictive of procedure failure. Statistical signif-
icance was assumed for a P value less than .05.
RESULTS
In the 12-month period between April 1999 and
March 2000, 131 femoral-distal bypass procedures were
performed at our institution. Remote SFA endarterec-
tomy was considered appropriate in 17 (13%) patients dur-
ing that time period. The demographics of those 17
patients are displayed in Table I. All patients had long-seg-
ment occlusion of the ipsilateral SFA with a patent, dis-
ease-free popliteal artery and a mean of 2.2 runoff tibial
vessels and a mean ABI of 0.52 in the group. Endovascular
remote SFA endarterectomy was attempted in all 17
patients; the procedure was technically feasible and com-
pleted in 11 patients (65%). Reasons for technical failure
(35%) included perforation of the SFA (4) including one
SFA avulsion, the inability to traverse a heavily calcified
segment of the SFA with the ring stripper (1), and the
inability to retract/retrieve the ring cutter from the distal
diseased segment of the SFA because of device failure (1)
(Table II). All of these patients underwent immediate con-
version to open surgical revascularization at the same
operative setting, including 4 femoral above-knee
popliteal bypass grafts, 1 femoral below-knee popliteal
bypass graft, and 1 femoral anterior tibial artery bypass
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graft. The two below-knee bypass grafts were necessary
because of the injury to the above-knee popliteal segment
resulting from extensive calcification at Hunter’s canal,
making it unfavorable for subsequent open revasculariza-
tion. All of these bypass grafts were performed with an 8-
mm polytetrafluoroethylene (PTFE) prosthetic conduit. A
distal vein cuff was used as an adjunct in the two cases
requiring below-knee revascularization in the absence of
ipsilateral greater saphenous vein conduit.
The remaining 11 patients had successful completion
of endovascular SFA endarterectomy with stenting of the
distal end point. Ten patients had 7 × 20-mm Symphony
(Boston Scientific, Natick, Mass) self-expanding stents
placed, whereas the remainder had a Palmaz 294 (Cordis,
Warren, NJ) balloon-expandable stent placed. All had an
excellent technical result with a widely patent SFA, and
there was no evidence of emboli on completion arteriog-
raphy. Palpable pedal pulses were restored in all these
cases. Mean increase in postprocedural ABI was 0.31 for
the group (range, 0.2-0.6). Postoperatively, patients were
given enteric-coated aspirin daily. Warfarin therapy was
continued in five patients who underwent anticoagulation
for unrelated reasons.
There were only five patients (29%) who maintained
patency of their endarterectomized SFA during this
study. Their mean length of follow-up was 10.3 months
(range, 4.7-12.3 months). All had a patent SFA without
significant flow velocity changes and no evidence for sig-
nificant stenosis on their most-recent duplex follow-up.
Primary SFA patency, including the six immediate fail-
ures, was 26% ± 11% at 1 year (Fig 3, Table III). Primary-
assisted patency was 38% ± 12% because one patient
underwent repeat SFA angioplasty/stenting before
rethrombosis of the SFA. If life-table analysis was limited
to the subset of 11 patients in whom the procedure was
technically successful, the 1-year primary and primary-
assisted patency rates were 40% ± 16% (Fig 4) and 59% ±
16%, respectively. Univariate life-table analysis, a Cox
proportional hazards model, and multiple logistic regres-
Table I. Patient demographics
Patients (N = 17)
Age and sex
Mean age (y) 64 ± 3
Male:Female 13:4
Comorbidities
CAD 65%
DM 59%
Smoking 65%
HTN 53%
Hyperlipidemia 41%
ESRD 6%
Indication
Claudication 47%
Rest pain 35%
Ulceration 18%
CAD, Coronary artery disease; DM, diabetes mellitus; ESRD, end-state
renal disease; HTN, hypertension.
Table II. Technical failures and outcomes
Complication Outcome
SFA perforation Femoral-AK popliteal bypass graft 
with PTFE
SFA perforation Femoral-BK popliteal bypass graft 
with PTFE/cuff
Inability to pass ring Femoral-AK popliteal bypass graft 
with PTFE
SFA avulsion Femoral-AT bypass graft with 
PTFE/cuff
Inability to remove ring Femoral-AK popliteal bypass graft 
with PTFE
SFA perforation Femoral-AK popliteal bypass graft 
with PTFE
AK, Above knee; AT, anterior tibia; BK, below knee; PTFE, polytetra-
fluoroethylene; SFA, superior femoral artery.
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sion for procedure success and patency revealed no reli-
ably predictive factors. However, the small study size lim-
ited statistical power.
In patients whose endarterectomy failed, all but one
required reintervention (Table IV). Four patients with
reocclusion underwent femoral-distal autogenous vein
reconstruction (2 below-knee popliteal, 2 tibial).
Because of the previous endarterectomy and the pres-
ence of a stent in the above-knee popliteal artery, as well
as extension of thrombosis at this level, infragenicular
revascularization was required in all cases. One patient
with a symptomatic restenosis in the proximal SFA iden-
tified on duplex surveillance underwent repeat percuta-
neous balloon dilation with a satisfactory result. Another
patient with claudication from multiple recurrent SFA
stenoses declined treatment and was managed conserva-
tively. The mean time to failure was 7.4 months (range,
3.3-10.9 months). The reocclusions presented as pri-
mary thrombosis after a surveillance duplex examination
with normal results. The site of restenosis/reocclusion
leading to failure was not consistent. Stenoses were
spread throughout the length of the native SFA and
were often multiple. However, recurrent stenoses were
not found in the distal stent.
DISCUSSION
Our experience with endovascular SFA endarterec-
tomy has been disappointing. The procedure was success-
ful in less than two thirds of patients, and in those in
whom the procedure was successful, a 1-year primary
patency rate of only 40% was achieved. Technical failures
cannot be explained by inexperience with the technique
Fig 4. Kaplan-Meier life-table analysis for primary patency in
patients in whom technical success was achieved. Life-table plot
for primary patency analyzing only the 11 study patients in whom
procedure could be completed and calculated with Kaplan-Meier
method. Twelve-month primary patency was 40% ± 15%.
Numbers indicate patients at risk for each time interval.
Fig 3. Kaplan-Meier life-table analysis for primary patency in all
patients. Life-table plot for primary patency including all 17 study
patients calculated with Kaplan-Meier method. Twelve-month
primary patency was 26% ± 11%. Numbers indicate patients at risk
for each time interval.
Table III. Life-table analysis, primary patency in successfully treated patients
Cumulative Cumulative Survival Cumulative Cumulative
Time (mo) Status survival failure SE events censor At risk
0 1.000 0.000 0.000 0 0 11
3.3 Uncensored .909 .091 .087 1 0 10
4.7 Censored .909 .091 .087 1 1 9
5.7 Uncensored .808 .192 .122 2 1 8
6.9 Uncensored .707 .293 .143 3 1 7
8.4 Uncensored .606 .394 .154 4 1 6
9.4 Uncensored .505 .495 .158 5 1 5
10.9 Uncensored .404 .506 .155 6 1 4
11.2 Censored .404 .596 .155 6 2 3
11.4 Censored .404 .596 .155 6 3 2
12.0 Censored .404 .596 .155 6 4 1
12.3 Censored .404 .596 .155 6 5 0
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because they were seen throughout the study and even
more in the latter phase. This may indicate that we were
more aggressive with the technique as we gained experi-
ence. It has been shown histologically that the use of ring
stripper devices creates an uneven and unpredictable dis-
section plane along a long segment of the SFA.20 This
coarse, exposed endarterectomized surface is likely the
source for the early failure encountered. The surface is
highly thrombogenic and a rich bed for intimal hyperpla-
sia. In addition, femoropopliteal calcification has been
described as a contraindication in the older open or semi-
closed techniques of SFA endarterectomy.21 Therefore,
poor patient selection may have been a factor in our two
technical failures involving the inability to pass or retract
the ring stripper because of a heavily calcified SFA. We did
not specifically quantify calcification, but varying degrees
of calcification should be demonstrable by preoperative
duplex examination, and a more rigorous preoperative
analysis might reduce complication rates.
Technical failures notwithstanding, the short-term
patency afforded by a successful procedure does not
approach the 45% 5-year patency rates achieved with pros-
thetic above-knee revascularization for which all of these
patients would have been eligible.9 It is possible that the
procedure may have some merit in selected patients. Five
of our patients had continued patency to a mean of 10
months. These were patients in the early part of our expe-
rience who, in retrospect, appear to have been better can-
didates. Unfortunately, the number of such patients was
too small to glean any plausible explanation or selection
criteria.
Moll et al renewed interest in SFA endarterectomy
with their description of the endovascular technique in
1995.15,19 Their initial results were promising, with 100%
technical success and a 96% 5-month patency. However,
their 2-year data, reported after our experience was already
under way, were worrisome, with a 46% restenosis rate at
5 months requiring aggressive surveillance and reinterven-
tion to improve primary-assisted patency rates from 47%
to 77%.16,22,23 Similar to our experience, the restenoses in
their series showed no predictable anatomical preference
along the endarterectomized SFA segment.22 Another
recent study has shown similar data to ours with a techni-
cal failure rate of 23% and, in successful procedures, 1- and
2-year primary patency rates of 40% and 29%, respectively.
The investigators found a 63% cumulative 1-year resteno-
sis rate and, with an aggressive approach to reintervention,
achieved a 72% primary-assisted patency rate.24 We have
had a less aggressive approach to reintervention. This,
combined with the fact that most failures in our series pre-
sented as primary thrombosis, led us to favor open surgi-
cal bypass grafting over percutaneous angioplasty for
reintervention.
This leaves the search for a durable endovascular
approach to femoropopliteal revascularization ongoing.
Other techniques such as transluminal atherectomy,25-29
laser SFA endarterectomy,30,31 and the Dotter technique
of serial dilation32 have been attempted for recanalization
of SFA occlusions with poor results and limited practical
applicability. The use of percutaneous balloon angioplasty
and stenting for infrainguinal femoropopliteal revascular-
ization has generally had poor results with limited durabil-
ity. Patency rates of 30% to 35% at 5 years for angioplasty
alone have been reported.33,34 The addition of primary
stenting has not significantly improved outcomes.35-37
Recent results of 52% 4-year anatomical patency are more
encouraging, but they were associated with clinical success
in only 40% over the same time interval.38
The next generation of SFA endarterectomy com-
bined with endoluminal femoropopliteal bypass grafting
has been described in an effort to combine SFA
endarterectomy and endovascular stent/graft technology.
This approach is in the developmental stages in a number
of cadaveric and animal models.39-41 In addition, human
clinical trials in which various devices (Cragg Endopro
System, Enduring-Gore, EVI-EndoVascular Instruments)
are used have begun to explore the endoluminal grafting
technique.42,43 In fact, Ho et al44 have modified their
original SFA endarterectomy technique to use the place-
ment of an endoluminal expanded PTFE graft showing
improved primary and secondary 2-year patency rates of
61% and 70% compared with endarterectomy alone.44
Even though endovascular SFA endarterectomy revi-
talized an approach to SFA occlusive disease, our results
and those of others using this technique have been dis-
appointing. We have abandoned the use of endovascular
SFA endarterectomy in its current form as a treatment
for femoropopliteal occlusive disease and await the
results of prospective evaluation of endoluminal grafting
techniques.
Table IV. Endarterectomy failures and outcomes
Failure Time (mo) Initial indication Failure symptom Outcome
Reocclusion 3.3 Claudication Claudication Femoral-BK popliteal bypass graft with NRSV
Reocclusion 5.7 Claudication Rest pain Femoral-PT bypass graft with ISSV
Reocclusion 6.9 Ulceration Rest pain Femoral-BK popliteal bypass graft with ISSV
Reocclusion 8.4 Claudication Claudication Femoral-tibial peroneal trunk bypass graft with ISSV
Restenosis (multiple) 9.4 Claudication Claudication Observation
Restenosis (proximal) 10.9 Rest pain Claudication SFA angioplasty
BK, Below knee; ISSV, in situ saphenous vein; NRSV, nonreversed saphenous vein; PT, posterior tibia; SFA, superficial femoral artery.
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